Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
2.730
-0.040 (-1.44%)
Nov 21, 2024, 4:00 PM EST - Market closed
Trevi Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 210 | 86 | 116 | 20 | 44 | 67 | |
| Market Cap Growth | 74.19% | -26.01% | 472.04% | -54.55% | -33.49% | - | |
| Enterprise Value | 149 | -2 | 1 | 6 | 5 | 4 | |
| Last Close Price | 2.77 | 1.34 | 1.93 | 0.78 | 2.42 | 3.75 | |
| PB Ratio | 3.54 | 1.04 | 1.08 | 1.18 | 1.63 | 1.23 | |
| P/TBV Ratio | 4.11 | 1.04 | 1.08 | 1.18 | 1.63 | 1.23 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.09 | 0.86 | 0.52 | 0.01 | |
| Quick Ratio | 7.18 | 14.25 | 8.99 | 2.89 | 8.10 | 11.13 | |
| Current Ratio | 7.38 | 15.03 | 9.15 | 2.98 | 8.33 | 11.45 | |
| Return on Equity (ROE) | -59.65% | -30.59% | -46.82% | -153.03% | -80.07% | -85.70% | |
| Return on Assets (ROA) | -36.57% | -19.96% | -23.15% | -47.42% | -37.91% | -47.22% | |
| Return on Capital (ROIC) | -39.89% | -21.15% | -25.18% | -55.37% | -42.13% | -53.47% | |
| Earnings Yield | -20.37% | -33.97% | -25.21% | -167.88% | -73.64% | -38.95% | |
| FCF Yield | -16.14% | -37.22% | -24.50% | -143.18% | -65.27% | -34.54% | |
| Buyback Yield / Dilution | -1.57% | -53.44% | -182.56% | -26.48% | -53.88% | -2581.79% | |
| Total Shareholder Return | -1.57% | -53.44% | -182.56% | -26.48% | -53.88% | -2581.79% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.